Search
Ascentage Pharma Group International
AAPGAdd to Watchlist
18.050USD
+0.090+0.50%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
6.74BMarket Cap
--P/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
9
analysts
Buy
Current Rating
47.750
Target Price
+171.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Ascentage Pharma Group International
AAPG
9
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is the analyst rating for Ascentage Pharma Group International?
Based on the ratings of Ascentage Pharma Group International's stock from 9 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.